Ignite Creation Date:
2024-05-06 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 12:49 PM
Study NCT ID:
NCT03597672
Status:
UNKNOWN
Last Update Posted:
2018-07-24
First Post:
2018-07-15
Brief Title:
Early Detection and Screening Strategy of Gatric Cancer in Sichuan Province-A Prospective Cohort Study WCH-GC-SIGES-01
Sponsor:
Jian-Kun Hu
Organization:
West China Hospital
Study Overview
Official Title:
A Prospective Cohort Study of Early Detection and Screening Strategy for Gatric Cancer in Sichuan Province China SIGES-01
Status:
UNKNOWN
Status Verified Date:
2018-07
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SIGES-01
Brief Summary:
To establish prospective cohort of healthy population and corresponding serum sample bank in Sichuan province to provide platform for exploring early diagnosis and screening strategy of gastric cancer by a prospective cohort study
Detailed Description:
H pylori was one of the most important carcinogenic factor for gastric cancer and play a crucial role in inducing gastritis atrophy and canceration Chronic atrophic gastritis CAG was a common precancerous disease people with CAG become high-risk population and need regular follow-up However study about occurrence risk prediction for gastric cancer when H pylori infection concurrence with CAG was still spare In especial there was still no population screening program based on serology The relative clinical epidemiology for providing evidence for China gastric cancer screening program was very rare
This study aim to evaluate gastric cancer occurrence risk and diagnostic value of people combined with H pylori infection and CAG by Serological methods in Sichuan province China We also project to design optimized screening program suitable for people in sichuan province China
This study aim to evaluate gastric cancer occurrence risk and diagnostic value of people combined with H pylori infection and CAG by Serological methods in Sichuan province China We also project to design optimized screening program suitable for people in sichuan province China
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 32027101815 | OTHER_GRANT | Wu Jieping Foundations special fund for clinical research | None |